article Expert view: Call to action: establishing the protein-binding properties of oligonucleotides 12 September 2019 | By NanoTemper The number of oligonucleotide-based platforms on the market is constantly increasing and has led to the emergence of innovative nucleic acid-based therapeutic modalities such as CRISPR-Cas, sgRNAs or mRNAs.